{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T04:16:44Z","timestamp":1742012204476,"version":"3.38.0"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,3,15]]},"DOI":"10.2169\/internalmedicine.3840-24","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T22:12:20Z","timestamp":1723241540000},"page":"959-963","source":"Crossref","is-referenced-by-count":0,"title":["Self-limited Giant Cell Arteritis: The Dilemma Associated with Its Diagnosis and Treatment"],"prefix":"10.2169","volume":"64","author":[{"given":"Koki","family":"Hirose","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Kanzawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuya","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishiro","family":"Tsuruta","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Mizuki","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Ishimaru","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Kinami","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Akashi Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Simon S, Ninan J, Hissaria P. Diagnosis and management of giant cell arteritis: major review. Clin Exp Ophthalmol 49: 169-185, 2021.","DOI":"10.1111\/ceo.13897"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ponte C, Grayson PC, Robson JC, et al. 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 81: 1647-1653, 2022.","DOI":"10.1002\/art.42325"},{"key":"3","unstructured":"3. Isobe M, Amano K, Arimura Y, et al. JCS 2017 Guideline on management of vasculitis syndrome - digest version. Circ J 84: 299-359, 2020."},{"key":"4","unstructured":"4. Maekawa M, Iwadate T, Watanabe K, Yamamoto R, Imaizumi T, Yamakawa T. Spontaneous remission of giant cell arteritis: possible association with a preceding acute respiratory infection and seropositivity to <i>Chlamydia pneumoniae<\/i> antibodies. Nagoya J Med Sci 81: 151-158, 2019."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. \u00c1lvarez-Lario B, Lorenzo-Mart\u00edn JA, Colazo-Burlato M, Macarr\u00f3n-Vicente JL, Alonso-Valdivielso JL. Giant cell arteritis with spontaneous remission. Mod Rheumatol Case Rep 6: 75-79, 2022.","DOI":"10.1093\/mrcr\/rxab001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cavazza A, et al. Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol 38: 1360-1370, 2014.","DOI":"10.1097\/PAS.0000000000000244"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jennings GH.  &quot;Temporal Arteritis&quot;. Some aspects of subacute arteritis in later life. Br Med J 1: 443-447, 1948.","DOI":"10.1136\/bmj.1.4548.443"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. \u00d6stberg G. Temporal arteritis in a large necropsy series. Ann Rheum Dis 30: 224-235, 1971.","DOI":"10.1136\/ard.30.3.224"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Singh R, Rajakulenthiran T, Silva S, Amarasena R. Acute visual loss without concurrent headaches due to ultrasound-negative, biopsy-proven giant cell arteritis. Clin Med 20: s58, 2020.","DOI":"10.7861\/clinmed.20-2-s58"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mishra K, Ramcharitar RK, Sharma AM. Vasculitis: when to consider this diagnosis? Med Clin North Am 107: 845-859, 2023.","DOI":"10.1016\/j.mcna.2023.05.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Arias M, Cacabelos P, Arias-Rivas S. Polymyalgia rheumatica and giant cell arteritis with intracranial involvement postvaccination anti-COVID-19. Med Clin 159: e43-e44, 2022.","DOI":"10.1016\/j.medcle.2022.04.011"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ishizuka DK, Katayama K, Ohira Y. Giant cell arteritis presenting with chronic cough and headache after BNT162b2 mRNA COVID-19 vaccination. QJM 115: 621-622, 2022.","DOI":"10.1093\/qjmed\/hcac171"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Liozon E, Parreau S, Filloux M, et al. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review. Autoimmun Rev 20: 102732, 2021.","DOI":"10.1016\/j.autrev.2020.102732"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Soriano A, Verrecchia E, Marinaro A, et al. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. Lupus 21: 153-157, 2012.","DOI":"10.1177\/0961203311430222"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Duhaut P, Bosshard S, Ducroix JP. Is giant cell arteritis an infectious disease? Biological and epidemiological evidence. Presse Med 33: 1403-1408, 2004.","DOI":"10.1016\/S0755-4982(04)98939-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rhee RL, Grayson PC, Merkel PA, Tomasson G. Infections and the risk of incident giant cell arteritis: a population-based, case-control study. Ann Rheum Dis 76: 1031-1035, 2017.","DOI":"10.1136\/annrheumdis-2016-210152"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Putman MS, Gribbons KB, Ponte C, et al. Clinicopathologic Associations in a Large International Cohort of Patients With Giant Cell Arteritis. Arthritis Care Res 74: 1013-1018, 2022.","DOI":"10.1002\/acr.24540"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 349: 160-169, 2003.","DOI":"10.1056\/NEJMra022694"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/6\/64_3840-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T03:30:56Z","timestamp":1742009456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/6\/64_3840-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3840-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"article-number":"3840-24"}}